GlassScriptPhysician profile
Joshua L Frame
NPI 1437143443
$10,093.25
in general payments reported to CMS, 2019-2025
60 companies · $1,491 in 2025
The $1,491 reported for 2025 was more than what 90% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,163 · 2020: $1,446 · 2021: $1,488 · 2022: $1,506 · 2023: $1,396 · 2024: $1,602 · 2025: $1,491.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,489 · Education: $0.79.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,488.68 |
| Education | $0.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,312.44 | 2020-2025 | |
| Novartis Pharmaceuticals Corporation | $972.86 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $910.77 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Pfizer INC. | $699.57 | 2019-2025 | |
| Novo Nordisk INC | $597.07 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $549.25 | 2020-2025 | Mounjaro, Jardiance, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $499.94 | 2019-2025 | Jardiance, Tradjenta, Synjardy |
| Amgen INC. | $492.48 | 2019-2025 | Krystexxa, Evenity, Prolia |
| Janssen Pharmaceuticals, INC | $296.35 | 2019-2024 | Xarelto |
| Boston Scientific Corporation | $252.82 | 2019-2025 | General - Pain Management, Artisan, Watchman Flx |
| Nestle Healthcare Nutrition INC. | $235.30 | 2020-2022 | |
| Sanofi-Aventis U.S. LLC | $227.32 | 2019-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $222.03 | 2019-2025 | Trintellix |
| Abbott Laboratories | $199.94 | 2019-2023 | Freestyle Libre 3 |
| Philips North America LLC | $189.09 | 2019-2021 |
Show all 59 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $181.40 | 2019-2025 | Capvaxive, Gardasil 9, Gardasil |
| Allergan, INC. | $160.13 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $148.52 | 2022-2025 | |
| Lundbeck LLC | $145.29 | 2023-2025 | Vyepti, Rexulti |
| Teva Pharmaceuticals USA, INC. | $135.28 | 2019-2022 | |
| Radius Health, INC. | $120.94 | 2023-2025 | Tymlos |
| Glaxosmithkline, LLC. | $115.50 | 2020-2023 | Trelegy Ellipta, Arexvy |
| Aimmune Therapeutics, INC. | $108.37 | 2024-2025 | Zenpep |
| Biohaven Pharmaceutical Holding Company LTD. | $92.32 | 2022 | |
| Neurocrine Biosciences, INC. | $88.21 | 2020-2021 | |
| Amarin Pharma, INC. | $86.04 | 2019-2021 | |
| Mylan Specialty L.P. | $84.69 | 2019-2024 | Yupelri |
| Dexcom, INC. | $82.51 | 2021-2025 | Dexcom G6 Transmitter |
| Daiichi Sankyo INC. | $79.17 | 2021-2025 | Injectafer |
| Biohaven Pharmaceuticals, INC. | $65.48 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $56.01 | 2025 | Rexulti |
| Ibsa Pharma INC. | $53.84 | 2020-2021 | |
| Horizon Therapeutics Plc | $46.13 | 2020-2023 | Krystexxa |
| Ironwood Pharmaceuticals, INC | $42.85 | 2019-2020 | |
| Almatica Pharma LLC | $38.60 | 2022 | |
| Medtronic, INC. | $34.10 | 2024-2025 | Venaseal |
| Alkermes, INC. | $31.73 | 2022-2023 | Lybalvi |
| Idorsia Pharmaceuticals US INC | $31.48 | 2024 | Quviviq |
| Exact Sciences Corporation | $30.41 | 2023-2024 | Cologuard Collection Kit |
| Ani Pharmaceuticals, INC. | $26.15 | 2023 | Purified Cortrophin Gel |
| Tactile Systems Technology INC | $25.54 | 2019-2021 | |
| Sumitomo Pharma America, INC. | $24.83 | 2023-2024 | Gemtesa |
| Viatris Specialty LLC | $24.68 | 2025 | Yupelri |
| Nevro Corp. | $22.67 | 2022 | |
| Vanda Pharmaceuticals INC. | $21.96 | 2021 | |
| Lucid Diagnostics INC. | $21.06 | 2023 | |
| Xeris Pharmaceuticals, INC. | $20.82 | 2024 | Gvoke Hypopen |
| Inspire Medical Systems, INC. | $20.17 | 2024 | Inspire |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $19.62 | 2025 | Caplyta |
| Strongbridge US INC. | $18.22 | 2019 | |
| Ge Healthcare | $18.12 | 2019 | |
| Urovant Sciences INC | $17.89 | 2021 | |
| Phathom Pharmaceuticals, INC. | $17.32 | 2024 | Voquezna |
| Kyowa Kirin, INC. | $15.79 | 2025 | |
| Baxter Healthcare | $14.72 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Esperion Therapeutics, INC. | $14.17 | 2020 | |
| Actelion Pharmaceuticals US, INC. | $13.49 | 2022 | |
| Eisai INC. | $12.51 | 2021 | |
| Insightec,INC | $7.29 | 2024 | Exablate |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Frame listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.